What to watch today: Stocks to rise on positive Covid vaccine, treatment news

What to watch today: Stocks to rise on positive Covid vaccine, treatment news

BY THE NUMBERSIN THE NEWS TODAYU.K. pharmaceutical giant AstraZeneca said Monday that late-stage trials of its Covid vaccine showed as much as 90% efficacy when participants received a half dose, followed by a full dose at least one month apart. When given as two full doses at least one month apart, effectiveness was lower at 62%. The AstraZeneca vaccine was developed in collaboration with the University of Oxford. (CNBC)The Pfizer (PFE)-BioNTech (BNTX) alliance and Moderna reported results showing that their respective vaccines were around 95% effective. Pfizer's vaccine could get British regulatory approval in this week, according to The Telegraph.* G-20 leaders pledge to ‘spare no effort' to ensure equitable vaccines access worldwide (CNBC)* Trump attends his final G-20 summit but does not participate in pandemic session (CNBC)The Food and Drug Administration on Saturday granted an emergency use authorization for Regeneron's antibody treatment, the experimental therapy given Trump when he contracted the coronavirus in October. The approval comes after the FDA announced on Nov. 9 emergency use authorization for Eli Lilly's antibody treatment. (CNBC)Merck (MRK) said Monday it plans to acquire privately held OncoImmune for $425 million in cash, gaining rights to an under-the-radar drug that has shown striking results